SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 63 filers reported holding SIERRA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,000 | -46.6% | 79,671 | -23.3% | 0.01% | -42.9% |
| Q2 2019 | $58,000 | -58.0% | 103,911 | +28.6% | 0.02% | -73.4% |
| Q1 2019 | $138,000 | -70.1% | 80,799 | -76.9% | 0.08% | -38.8% |
| Q4 2018 | $461,000 | -31.2% | 349,258 | -11.4% | 0.13% | -10.4% |
| Q3 2018 | $670,000 | +57.3% | 394,258 | +173.8% | 0.14% | +63.6% |
| Q2 2018 | $426,000 | +769.4% | 143,991 | +512.2% | 0.09% | +877.8% |
| Q1 2018 | $49,000 | – | 23,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |